Who founded Akero Therapeutics, Inc.?

Akero Therapeutics, Inc. was founded by Andrew Cheng in 2017.

Who are Akero Therapeutics, Inc.'s investors?

Akero Therapeutics, Inc.'s investors include Atlas Venture, venBio Partners.

How much funding has Akero Therapeutics, Inc. raised?

Akero Therapeutics, Inc. has disclosed $45.5M raised across 1 round.

Where is Akero Therapeutics, Inc. headquartered?

Akero Therapeutics, Inc. is headquartered in South San Francisco, US.

Akero Therapeutics, Inc.

South San Francisco, US · Founded 2017 · 2 known investors

Find your way into Akero Therapeutics, Inc.

213 people in our graph share verified history with the Akero Therapeutics, Inc. team — schools, employers, funds. One of them is your warm intro.

Clint Myersunlockedknows Jonathan Young · together at The University of North Carolina at Chapel Hill (overlapped)

×3knows the team · via The University of North Carolina at Chapel Hill

×8knows the team · via Yale Law School

Healthtech

Founders & leadership

Akero Therapeutics, Inc. was founded in 2017 by Andrew Cheng.

Andrew ChengFounder

Jonathan Young inExecutiveJonathan Young holds senior executive positions spanning biotechnology drug development, law, and policy across private industry, government, and nonprofit sectors. He is an executive officer at Akero Therapeutics, Inc.

Board

Aaron KantoffBoard director

Aaron Royston in 𝕏Board directorManaging Partner at venBio Partners

Graham WalmsleyBoard director

Kevin Bitterman in 𝕏Board directorPartner at Atlas Venture

Mark IwickiBoard director

Investors · 2

Atlas VenturereportedCambridge · $500K – $1Mvia Kevin Bitterman · board

venBio PartnersreportedSan Franciscovia Aaron Royston · board

Reported raises · per SEC filings

Form D private placements

$45.5M disclosed across 1 round · 2018

▶$45.5MraisedDec 2018 · 20 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Aaron KantoffDirector
Aaron RoystonDirector
Mark IwickiDirector
Graham WalmsleyDirector
Jonathan YoungExecutive Officer
Kevin BittermanDirector
Andrew ChengExecutive Officer, Director

Offering amount: $45.5M
Amount sold: $45.5M
First sale: Dec 2018
Incorporated: Corporation, Delaware, 2017
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who founded Akero Therapeutics, Inc.?: Akero Therapeutics, Inc. was founded by Andrew Cheng in 2017.
Who are Akero Therapeutics, Inc.'s investors?: Akero Therapeutics, Inc.'s investors include Atlas Venture, venBio Partners.
How much funding has Akero Therapeutics, Inc. raised?: Akero Therapeutics, Inc. has disclosed $45.5M raised across 1 round.
Where is Akero Therapeutics, Inc. headquartered?: Akero Therapeutics, Inc. is headquartered in South San Francisco, US.